Search Results - Sara Galimberti
- Showing 1 - 20 results of 46
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Different types of amyloid concomitantly present in the same patients by Francesca Martini, Gabriele Buda, Vincenzo De Tata, Sara Galimberti, Enrico Orciuolo, Matilde Masini, Mario Petrini
Published in Hematology Reports (2019-12-01)Get full text
Article -
8
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study by Hakan Savlı, Sara Galimberti, Deniz Sünnetçi, Martina Canesastraro, Giuseppe Palumbo, Balint Nagy, Francesco Di Raimondo, Mario Petrini
Published in Turkish Journal of Hematology (2015-07-01)Get full text
Article -
9
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study by Hakan Savlı, Sara Galimberti, Deniz Sünnetçi, Martina Canestraro, Giuseppe Palumbo, Balint Nagy, Francesco Di Raimondo, Mario Petrini
Published in Turkish Journal of Hematology (2015-09-01)Get full text
Article -
10
Prethymic Cytoplasmic CD3 Negative Acute Lymphoblastic Leukemia or Acute Undifferentiated Leukemia: A Case Report by Elisa Cannizzo, Giovanni Carulli, Luigi Del Vecchio, Antonio Azzarà, Sara Galimberti, Virginia Ottaviano, Frederic Preffer, Mario Petrini
Published in Case Reports in Hematology (2011-01-01)Get full text
Article -
11
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results by Rita Fazzi, Iacopo Petrini, Nicola Giuliani, Riccardo Morganti, Giovanni Carulli, Benedetta Dalla Palma, Laura Notarfranchi, Sara Galimberti, Gabriele Buda
Published in Frontiers in Immunology (2021-02-01)Get full text
Article -
12
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy by Raffaele Palmieri, Atto Billio, Felicetto Ferrara, Sara Galimberti, Roberto M. Lemoli, Roberto M. Lemoli, Elisabetta Todisco, Federico Moretti, Adriano Venditti
Published in Frontiers in Oncology (2024-02-01)Get full text
Article -
13
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial... by Stefano Luminari, Sara Galimberti, Annibale Versari, Irene Biasoli, Antonella Anastasia, Chiara Rusconi, Angela Ferrari, Mario Petrini, Martina Manni, Massimo Federico
Published in Haematologica (2016-02-01)Get full text
Article -
14
Joint Pain and Arthritis as First Clinical Manifestation of Systemic Amyloidosis and Multiple Myeloma: Case Report and Brief Literature Review by Francesco Mazziotta, Gabriele Buda, Maria Livia Del Giudice, Enrico Orciuolo, Edoardo Benedetti, Matilde Masini, Vincenzo De Tata, Sara Galimberti, Mario Petrini
Published in Hematology Reports (2022-03-01)Get full text
Article -
15
A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia by Sara Galimberti, Elisabetta Abruzzese, Giacomo Luci, Claudia Baratè, Luigia Luciano, Alessandra Iurlo, Giovanni Caocci, Riccardo Morganti, Fabio Stefanelli, Antonello Di Paolo
Published in Pharmaceutics (2024-03-01)Get full text
Article -
16
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation by Federica Ricci, Serena Balducci, Francesca Guerrini, Susanna Grassi, Elena Ciabatti, Claudia Baratè, Maria Immacolata Ferreri, Cecilia Giuliani, Angelo Valetto, Mario Petrini, Sara Galimberti
Published in Clinical Hematology International (2020-07-01)Get full text
Article -
17
Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations? by Giovanni Fulvio, Giovanni Fulvio, Chiara Baldini, Marta Mosca, Antonello di Paolo, Guido Bocci, Giuseppe Alberto Palumbo, Emma Cacciola, Paola Migliorini, Rossella Cacciola, Sara Galimberti
Published in Frontiers in Medicine (2023-10-01)Get full text
Article -
18
Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients by Edoardo Benedetti, Edoardo Benedetti, Ginevra Traverso, Giulia Pucci, Riccardo Morganti, Emilia Bramanti, Federica Cavallo, Federica Cavallo, Enrico Capochiani, Maurizio De Maria, Vittorio Ricchiuto, Massimo Salvatore Stella, Sara Galimberti
Published in Frontiers in Oncology (2024-05-01)Get full text
Article -
19
The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose by Fabio Fiorino, Anna Sicuranza, Annalisa Ciabattini, Adele Santoni, Gabiria Pastore, Martina Simoncelli, Jacopo Polvere, Sara Galimberti, Stefano Auddino, Claudia Baratè, Francesca Montagnani, Vincenzo Sammartano, Monica Bocchia, Donata Medaglini
Published in Biomedicines (2021-10-01)Get full text
Article -
20
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study by Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, Enrico Orciuolo, Francesco Ghio, Sara Ciofini, Veronica Candi, Giulia Fontanelli, Irene Attucci, Giuseppe Formica, Monica Bocchia, Sara Galimberti, Mario Petrini, Gabriele Buda
Published in Medicina (2021-08-01)Get full text
Article
